InsidersTradesSigma
Track the NewAmsterdam Pharma Company N.V. stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). The latest transaction was filed on 25 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: Kastelein Johannes Jacob Pieter. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
NewAmsterdam Pharma Company N.V. is a biopharmaceutical company focused on developing innovative treatments for cardiometabolic diseases. It is listed on NASDAQ under the ticker symbol NAMS.